VALENCIA, Calif., May 06, 2020 (GLOBE NEWSWIRE) — SetPoint Medical, a clinical-stage bioelectronic medicine company developing therapy for chronic autoimmune diseases, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA)?to study its proprietary bioelectronic platform in patients with rheumatoid arthritis (RA).
News Ticker
- [ November 30, 2023 ] Key Account Director (CA Region) – Kite Pharma – Anaheim, CA Los Angeles Biotech Jobs
- [ November 30, 2023 ] Director, National Accounts Payer – Kite Pharma – Los Angeles, CA Los Angeles Biotech Jobs
- [ November 30, 2023 ] Drug prices in TV ads again? Senators take another swing with expedited bill Los Angeles Biotech News
- [ November 30, 2023 ] IEHP-sponsored art contest adds colorful display to Coachella Valley bus line Los Angeles Biotech News
- [ November 30, 2023 ] Manufacturing Technician Pharmaceutical / Biotech / FDA Full Time $22+ – Grifols – Los Angeles, CA Los Angeles Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
